MMP-7-IN-3 features a peptide-like inhibitor scaffold used to study matrix metalloproteinase recognition and catalytic-site interactions. Its functional groups enable probing of binding geometry and steric complementarity. Researchers analyze its stability and solvation behavior. Applications include enzymatic profiling, inhibitor optimization, and mechanistic studies.
CAT No: R2510
CAS No:2865097-58-9
Synonyms/Alias:MMP-7-IN-3;CHEMBL5417105;2865097-58-9;BDBM50630413;DA-65559;HY-156430;CS-0901121;
Mmp-7-IN-3 is a specialized carbohydrate compound recognized for its potent inhibitory activity against matrix metalloproteinase-7 (MMP-7), an enzyme implicated in various physiological and pathological processes. As a highly selective small molecule inhibitor, Mmp-7-IN-3 is widely utilized in scientific research to dissect the intricate roles of MMP-7 in cellular dynamics, extracellular matrix remodeling, and tissue homeostasis. Its chemical structure allows for targeted interaction with the active site of MMP-7, making it a valuable tool for elucidating the molecular mechanisms underpinning enzyme function and regulation. Researchers appreciate its stability, solubility, and compatibility with a range of in vitro and in vivo experimental systems, which enables precise modulation of MMP-7 activity in diverse biological contexts.
Cancer Biology Research: Mmp-7-IN-3 serves as a critical investigative tool in oncology studies focused on tumor progression, invasion, and metastasis. By selectively inhibiting MMP-7 activity, researchers can examine the enzyme's contribution to the degradation of extracellular matrix components, which facilitates tumor cell migration and invasion. The compound enables the delineation of MMP-7-dependent pathways in cancer cell lines and animal models, offering insights into how the enzyme influences tumor microenvironment remodeling, angiogenesis, and interactions with stromal cells. These findings can inform the development of novel therapeutic approaches targeting MMP-7-mediated processes in malignancies.
Inflammation and Tissue Remodeling: In the context of inflammatory diseases, Mmp-7-IN-3 is employed to investigate the enzyme's role in modulating immune cell infiltration, cytokine release, and tissue repair mechanisms. By blocking MMP-7 activity, scientists can assess how the compound affects the turnover of matrix proteins and the regulation of inflammatory mediators in models of chronic inflammation. This approach is particularly valuable for unraveling the molecular pathways that drive tissue remodeling in disorders such as arthritis, fibrosis, and inflammatory bowel disease, thereby enhancing our understanding of disease pathogenesis and progression.
Fibrotic Disease Models: The selective inhibition provided by Mmp-7-IN-3 is instrumental in studies of fibrotic diseases, where excessive extracellular matrix deposition leads to tissue dysfunction. Researchers use the compound to dissect the contributions of MMP-7 to the activation of fibroblasts, processing of bioactive molecules, and regulation of matrix components in models of liver, lung, and kidney fibrosis. By modulating MMP-7 activity, it becomes possible to identify the enzyme's specific roles in the initiation and progression of fibrotic responses and to explore potential molecular targets for antifibrotic interventions.
Neuroscience and Neuroinflammation: Mmp-7-IN-3 has found application in neuroscience research, particularly in studies exploring the enzyme's involvement in neuroinflammatory and neurodegenerative processes. The compound enables investigators to probe the effects of MMP-7 inhibition on blood-brain barrier integrity, neuronal survival, and glial cell activation in models of central nervous system injury or disease. These studies contribute to a deeper understanding of the molecular events that govern neuroinflammation, synaptic remodeling, and neuronal plasticity, supporting the identification of new avenues for neuroprotective strategies.
Drug Discovery and Mechanistic Enzyme Studies: As a highly specific MMP-7 inhibitor, Mmp-7-IN-3 is extensively utilized in drug discovery platforms and mechanistic enzymology research. Its use in high-throughput screening assays allows for the evaluation of compound libraries for synergistic or additive inhibitory effects, while its well-characterized mechanism of action provides a reference point for structure-activity relationship studies. Researchers leverage its properties to validate target engagement, optimize lead compounds, and gain mechanistic insights into the structural determinants of MMP-7 inhibition, which are essential for the rational design of next-generation enzyme inhibitors.
The versatility of Mmp-7-IN-3 extends across a broad spectrum of biomedical research fields, where it enables precise functional analysis of MMP-7 and its downstream pathways. By facilitating the dissection of enzyme-mediated processes in cancer, inflammation, fibrosis, neurobiology, and drug discovery, this carbohydrate compound empowers scientists to unravel complex biological mechanisms and advance translational research. Its application fosters the development of innovative therapeutic strategies and contributes to the expanding knowledge base surrounding matrix metalloproteinases and their roles in health and disease.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.